Checkerspot and Huvepharma Partner to Commercialize Groundbreaking Human Milk Fat Analog
3 Articles
3 Articles
Checkerspot and Huvepharma Join Forces to Scale Sustainable Human Milk Fat Alternative
Checkerspot, a biotechnology company and Certified B Corporation specializing in renewable oils and fats from microalgae, has partnered with Huvepharma, a global biopharmaceutical and fermentation leader, to produce and commercialize high sn-2 palmitate algal oil at an industrial scale, a precision-fermented alternative to palm-derived oils that closely replicates the triglyceride structure found in human milk fat.Climate Change
Checkerspot and Huvepharma Partner to Commercialize Groundbreaking Human Milk Fat Analog
Clearing a Major Technological Hurdle, Checkerspot & Huvepharma Ready to Scale Production of the Novel, Direct Analog for Human Milk Fat October 07, 2025 12:00 ET | Source: Checkerspot Alameda, Calif (USA) and Sofia (Bulgaria), Oct. 07, 2025 (GLOBE NEWSWIRE) — Checkerspot, a biotechnology company and Certified B Corporation that develops renewable oils and fats […] The post Checkerspot and Huvepharma Partner to Commercialize Groundbreaking Huma…
Checkerspot teams up with Huvepharma to produce human milk fat analog at scale
Checkerspot—a startup making high-value lipids via fermentation of microalgae—has teamed up with Bulgarian biopharma co Huvepharma to produce the human milk fat analog OPO (Oleic-Palmitic-Oleic or sn-2 palmitate) at industrial scale. The lipid helps babies absorb essential nutrients such as calcium and fat-soluble micronutrients and confers immunological and anti-inflammatory properties, says CEO John Krzywicki, who says Checkerspot has “receive…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium